Plain-English translation of NCT03508960 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Parkinson Disease research guide →This is a research registry — essentially a database — that aims to enroll 3,000 people with early-onset Parkinson's disease (diagnosed before age 50) in China. Researchers will collect detailed information about your symptoms, medical history, family background, and environmental exposures. They will also take a blood sample to study your genes, helping them understand why some people develop Parkinson's disease at a younger age.
Early-onset Parkinson's disease is different from the more common type that appears later in life, and doctors still don't fully understand why some people get it so young or what role genes and environment play. This registry will help researchers identify patterns and risk factors specific to younger patients, which could eventually lead to better treatments and prevention strategies.
You likely qualify if…
You likely don't qualify if…
You would visit the research center where doctors will evaluate your Parkinson's symptoms using standard rating scales and tests. You'll answer detailed questionnaires about your medical history, lifestyle habits (such as smoking and pesticide exposure), and sleep patterns. Finally, researchers will collect a blood sample for genetic analysis. The exact number of visits and follow-up schedule have not been specified, but you should expect comprehensive assessments of your symptoms and health.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
China
Sponsor
Xiangya Hospital of Central South University
Enrollment target
~3,000 participants
Started
February 2017
Primary completion
February 2027
Last updated on clinicaltrials.gov in May 2018.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
J Guo, Ph.D.
Xiangya Hospital of Central South University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.